While full-scale applications are still in development, there have been promising pilot projects:
IBM and other tech giants are actively working on quantum algorithms for drug discovery. Startups like D-Wave have begun offering quantum cloud services that researchers can use for preliminary cancer studies. Collaborations between tech companies and research institutions aim to leverage quantum computing for genomic sequencing.
